ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Nashville, TN, USA:

XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer (1-BETTER)

ONIVYDE + LV + 5-FU chemotherapy regimen in patients with advanced pancreatic cancer and to determine the recommended dose for the ...

Active, not recruiting
Pancreatic Cancer
Biological: XB2001 or Placebo

Phase 1, Phase 2

XBiotech

Nashville, Tennessee, United States and 27 other locations

phosphorylase (MTAP)-deleted gastrointestinal, biliary tract, or pancreatic cancers. The study also aims to determine the safety pr...

Enrolling
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Drug: Gemcitabine
Drug: AMG 193

Phase 1

Amgen
Amgen

Nashville, Tennessee, United States and 70 other locations

and clinical activity of AB680 in combination with zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...

Active, not recruiting
Advanced Pancreatic Cancer
Drug: Zimberelimab
Drug: Gemcitabine

Phase 1

Arcus Biosciences
Arcus Biosciences

Nashville, Tennessee, United States and 15 other locations

This is a single arm study evaluating the tolerability and markers of pancreatic cancer with a specially designed medical food rest...

Active, not recruiting
Metastatic Pancreatic Adenocarcinoma
Locally Advanced Unresectable Pancreatic Adenocarcinoma
Other: NEAAR Medical Food
Faeth Therapeutics

Nashville, Tennessee, United States and 9 other locations

compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...

Active, not recruiting
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2

Agenus
Agenus

Nashville, Tennessee, United States and 35 other locations

or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Cancer Stage IV
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2, Phase 3

Panbela Therapeutics

Nashville, Tennessee, United States and 91 other locations

evaluate the efficacy, safety, and tolerability of futibatinib in combination with PD-1 antibody-based SoC therapy in adult patients with solid tumors...

Active, not recruiting
Siewert Type 1 GEJ Cancer
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer
Drug: Oxaliplatin
Drug: Futibatinib

Phase 2

Taiho Pharma
Taiho Pharma

Nashville, Tennessee, United States and 21 other locations

The study is a multi-center, open-label, randomized active controlled study of subjects with locally advanced pancreatic adenocarcinoma whic...

Enrolling
Locally Advanced Pancreatic Cancer
Device: RenovoCath
Drug: nab-paclitaxel

Phase 3

RenovoRx

Nashville, Tennessee, United States and 41 other locations

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.

Enrolling
PDAC - Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer
Drug: 5-fluorouracil
Drug: leucovorin

Phase 3

Revolution Medicines
Revolution Medicines

Nashville, Tennessee, United States and 46 other locations

This study will assess the safety and efficacy of VS-7375 alone and in combination in patients with advanced solid tumors harboring a KRAS G...

Enrolling
Solid Tumor, Adult
Non Small Cell Lung Cancer
Drug: Cetuximab
Drug: VS-7375

Phase 1, Phase 2

Verastem

Nashville, Tennessee, United States and 2 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems